# Schweitzer Engineering Laboratories Begins Clinical Trial for Autism Pupil-Response Device

> Schweitzer Engineering Laboratories launched a clinical trial for its first medical device, a pupil-response autism screening tool.

- Published: 2026-11-17T03:23:00+00:00
- Section: Research & Clinical Trials
- Author: News Desk
- URL: https://newsforagent.com/news/2026-11-17/schweitzer-engineering-autism-device-trial
- Source: [Yahoo](https://www.yahoo.com/news/science/articles/schweitzer-engineering-laboratories-takes-autism-030400490.html)

## Key takeaways

- Schweitzer Engineering Laboratories launched a clinical trial for its first medical device, which detects atypical pupil reactions to light associated with autism.
- The trial runs with the SEL Health Clinic, Palouse Pediatrics and other pediatric and family medicine clinics in the Inland Northwest.
- Principal scientist Georgina Lynch developed the device while an associate professor at Washington State University, and SEL acquired the prototype and Lynch in 2024.

Schweitzer Engineering Laboratories announced on November 16 the launch of a clinical trial for its first medical device, which detects atypical reactions to light in a child's pupils that research has associated with autism. The Pullman-based company said the trial is being conducted with clinics in the Inland Northwest and aims to gather data for FDA approval, [Yahoo](https://www.yahoo.com/news/science/articles/schweitzer-engineering-laboratories-takes-autism-030400490.html) reported.

## Inside the SEL Autism Screening Trial

[Schweitzer Engineering Laboratories](https://akta.pro/company-profiles/00074c4/schweitzer-engineering-laboratories) is a 100% employee-owned manufacturer of digital protective relays, automation controllers, networking and cybersecurity systems for electric utilities and critical infrastructure operators, selling across 170+ countries.

The device was developed by Georgina Lynch, now principal scientist in research and development at SEL, while she was an associate professor at Washington State University. "It's really exciting to see this milestone being met," Lynch said. "Words can't describe."

The trial is being conducted with the SEL Health Clinic, Palouse Pediatrics and other pediatric and family medicine clinics in the Inland Northwest, according to a company news release. Lynch said clinician teams were trained on the device and the study's parameters ahead of time.

Lynch said the trial has two purposes: to gain data for the Federal Drug Administration to assist in its decision on approving the device, and to learn how well the device performs in a clinical setting. Results of the device screening will be cross-referenced with a full diagnostic panel for autism.

"If we can bolster this screening process through adding this physical marker and making it easier in the process, if we can help prevent the wait time and get kids in more quickly, that's the ultimate goal," Lynch said.

SEL founder Edmund Schweitzer said in the release that the device could help "children and families access the support they need sooner." "Autism has touched my family and countless others. That is why this clinical trial is so important," he said.

## SEL's Scale Behind the Device

According to akta.pro [company records](https://akta.pro/company-data), SEL was founded in 1984 and is headquartered in Pullman, with a headcount range of 5,001 to 10,000 and a revenue estimate of $1 billion-$5 billion. The same records list 7,400+ employees at 100+ locations and products sold and served in 170+ countries. SEL joined the Department of Energy's CyTRICS program in March 2021, which focuses on identifying vulnerabilities in the technology supply chain.

## Earlier SEL Partnerships This Fall

In October 2026, Nozomi Networks and SEL expanded their global partnership to combine OT SDN visibility, ruggedized security monitoring and lifecycle cybersecurity services, PR Newswire reported. That same month, Washington State University and SEL partnered on wildfire research to address Pacific Northwest challenges, developing a regional assessment and research concepts aligned with industry and community priorities, Yahoo reported. On October 1, 2026, SEL announced a $25 million expansion at its West Lafayette, Indiana facility expected to create about 130 jobs, Inside Indiana Business reported.

## What Comes Next for the Device

SEL acquired the prototype and Lynch in 2024 with the intent of bringing the device to market. Lynch's earlier research includes a pilot study involving a penlight at the WSU Spokane campus in 2015.

## Companies in this story

- [Schweitzer Engineering Laboratories company profile](https://akta.pro/company-profiles/00074c4/schweitzer-engineering-laboratories) · website: http://www.selinc.com

---
News for Agent · https://newsforagent.com/llms.txt
